High frequency of isolation of antibiotic-resistant oral viridans streptococci from children in Kuwait

Journal of Chemotherapy

Volumn 17, Issue 5, 2005, Pages 493-501

  Rotimi, V O ^a   Salako, N O ^a   Mokaddas, E ^a   Philip, L ^a   Rajan, P ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antibiotic susceptibility; Oral streptococci; Viridans streptococci

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFUROXIME; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; PENICILLIN G; PIPERACILLIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILDHOOD DISEASE; DIAGNOSTIC ACCURACY; DILUTION; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; KUWAIT; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; NORMAL HUMAN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SPECIES DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; TONGUE; TOOTH;

EID: 28144441862     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.5.493     Document Type: Article

References (36)

1. Roberts RB, Krieger AG, Schiller NL, Gross KC. Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci. Rev Infect Dis. 1979; 1:955-961
2. Bochud P, Eggiman YP, Calandra T, Van Melle G, Saghafi L, Francioli P. Bacteremia due to Viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 1994; 18:25-31.
3. Venditti M, Baiocchi C, Santini C, et al. Antimicrobial susceptibilities of streptococcus species that cause septicemia in neutropenic patients. Antimicrob Agents Chemother. 1989; 33:58-582.
4. McWhinney PHM, Patel S, Whiley RA, Hardie JM, Gillespie, Kibbler CC. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of Viridans streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother. 1993; 37:2493-2495.
5. Brook I. Veillonella infections in children. J Clin Microbiol. 1996;34: 1283-1285.
6. Ready D, Bedi D, Spratt DA, Mullany P, Wilson M. Prevalence, proportions and identities of antibiotic-resistant bacteria in the oral microflora of healthy children Microb Drug Resist 2003; 9:367-372.
7. Roberts AP, Cheah G, Ready D, Pratten J, Wilson M, Mullany P. Transfer of Tn916-like elements in microcosm dental plaques. Antimicrob Agents Chemother 2001; 45:2943-2946.
8. Bryskier A. Viridans group streptococci: a reservoir of resistance bacteria in oral cavities. Clin Microbiol Infect. 2002; 8:65-69.
9. Reichmann P, Konig A, Linares J. A global gene pool for high level cephalosporin resistance in commensal Streptococcus species and S. pneumoniae. J Infect Dis 1997; 176: 1001-1012.
10. Millar MR, Walsh TR, Linton CJ, Zhang S, Leeming JP, Bennett PM. Carriage of antibiotic-resistant bacteria by healthy children. J Antimicrob Chemother. 2001; 47:605-610.
11. Guiot HFL, Corel LJA, Vossen JMJ. Prevalence of penicillin-resistant Viridans streptococci in healthy children and in patients with malignant haematological disorders. Eur J Clin Microbiol Infect Dis. 1994; 13:645-650.
12. Isenberg HD, Baron JE, D'Amato RF, et al. Recommendation for isolation of bacteria from clinical specimen. In Forrest KV, Baron EJ, Murray PR (eds): Manual of Clinical Microbiology, ed 5. Washington, ASM Press, 1991: 98-132.
13. Doem GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the Unites States. Antimicrob Agents Chemother 1996; 40:891-894.
14. Rennerberg J, Niemann LL, Cutchik E. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J Antimicrob Chemother. 1997; 39:135-140.
15. th Informational Supplement: Approved Standard M100-S12. Wayne PA: NCCLS; 2002; 22:68-70.
16. Coykendall AL. Classification and identification of the Viridans streptococci. Clin Microb Rev 1989; 2:315-328.
17. Abigail AS, Dixie DW. Microbiology, Diversity, Diseases and the Environment. Fitzgerald Science Press, Bethesda, Maryland; 2001.
18. Marsh PD, Martin MV. The resident oral flora. In: Oral Microbiology (ed) Marsh PD and Martin MV. London: Chapman & Hall. 1999; 27-55.
19. Ono T, Shiota S, Hirota K, Nemoto K, Tsuchiya T, Miyake Y. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother 2000; 44:1078-1080.
20. Higuera A, Castillo A, Gutierrez J, Garcia-Mendoza A, Liebana J. In vitro susceptibility, tolerance and glycocalyx production in Streptococcus mutans. J Antimicrob Chemother 1997; 40:359-363.
21. Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT. Antimicrobial susceptibility of Viridans group streptococci in Taiwan with an emphasis on high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998; 41:621-627.
22. De Azavedo JCS, Trpeski L, Pong-Porter S, Matsumura S. The Canadian Bacterial Surveillance Network and Low, DE. In vitro activities of fluroquinolones against antibiotic-resistant blood culture isolates of Viridans group streptococci from Canada. Antimicrob Agents Chemother. 1999; 43:2299-2301.
23. Wu JJ, Lin KY, Hsuen PR, Liu JW, Pan HI, Sheu SM. High incidence of erythromycin resistant streptococci in Taiwan. Antimicrob Agents Chemother 1997; 41:844-846.
24. Jacobs JA, Stobberingh EE. In-vitro antimicrobial susceptibility of the 'Streptococcus milleri' group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 1996; 37:371-375.
25. Aracil B, Minambres M, Olio J, Torres C, Gomez-Garces JL, Alos JI. High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) Viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J Antimicrob Chemother. 2001; 592-594.
26. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65:232-260.
27. British National Formulary. Antibacterial drugs. British Medical Association and the Royal Pharmaceutical Society of Great Britain. UK. 2002; 254-292.
28. Mullany P. Gene transfer in the GI tract and oral cavity. Microbiol Ecol Health Dis. 2000; 12:73-80.
29. Lancaster H, Ready D, Mullany P, Spratt D, Bedi R, Wilson M. Prevalence and identification of tetracycline resistant oral bacteria in children not receiving antibiotic therapy. FEMS Microbiol Letts. 2003; 228:99-104.
30. Bourgault AM, Wilson WR, Washington JA. Antimicrobial susceptibilities of species of Viridans streptococci. J Infect Dis. 1979; 140:316-321.
31. Parillo JE, Borst GC, Mazur MH et al. Endocarditis due to resistant Viridans streptococci during oral penicillin chemoprophylaxis N Engl J Med. 1979; 300:296-300.
32. Konig A, Reinert RR, Hakenbeck R. Streptococcus mitis with unusually high level resistance to beta-lactam antibiotics. Microb Drug Resist. 1998; 4:45-49.
33. Ahmed K, Martinez G, Wilson S, et al. The prevalence and clonal diversity of penicillin resistant Streptococcus pneumoniae in Kuwait. Epidemiol Infect. 2000; 125:573-581.
34. Mokaddas EM, Wilson S, Sanyal SC. Prevalence of penicillin resistant Streptococcus pneumoniae in Kuwait. J Chemother. 2001; 13:154-160.
35. Traub WH, Leonhard B. Antibiotic susceptibilities of non-hemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs. Chemotherapy 1997;43:123-31.
36. Wisplinghoff H, Reinert RR, Comely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of Viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol. 1999; 37:1876-1880.